News FDA Warning Letter: MedOffice Saglik Endustri Anonim Sirketi 3 November 2024 gmpinsiders he FDA inspection at MedOffice Saglik Endustri Anonim Sirketi revealed significant CGMP violations that could jeopardize product quality and consumer safety. Issues ranged from inadequate testing of drug products to…
News FDA Warning Letter Analysis: Diamond Chemical Co., Inc. 1 October 2024 gmpinsiders FDA issues a Warning Letter to Diamond Chemical Co., Inc. for cGMP violations, highlighting deficiencies in component testing, batch release, process validation, and stability testing. Explore the corrective actions and…
News FDA Issues Warning Letter to LS Promotions Inc. for cGMP Violations 13 August 2024 gmpinsiders FDA issues warning to LS Promotions Inc. for significant cGMP violations. Learn about the key deficiencies, recommended CAPA plan, and steps for compliance.
News FDA Issues Warning Letter Due to cGMP Violations 2 July 2024 gmpinsiders FDA issues warning to for CGMP violations. Addressing insanitary conditions, quality control, lab testing, and component verification.
